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Bovine tuberculosis remains one of the most damaging diseases to agriculture, and there is also a concern for human spillover. A
critical need exists for rapid, thorough, and inexpensive diagnostic methods capable of detecting and differentiatingMycobacte-
rium bovis infection from other pathogenic and environmental mycobacteria at multiple surveillance levels. In a previous study,
Seth et al. (PLoS One 4:e5478, 2009, doi:10.1371/journal.pone.0005478) identified 32 host peptides that specifically increased in
the blood serum ofM. bovis-infected animals). In the current study, 16M. bovis proteins were discovered in the blood serum
proteomics data sets. A large-scale validation analysis was undertaken for selected host andM. bovis proteins using a cattle se-
rum repository containingM. bovis (n 128),Mycobacterium kansasii (n 10), andMycobacterium avium subsp. paratuber-
culosis (n 10), cases exposed toM. bovis (n 424), and negative controls (n 38). Of the host biomarkers, vitamin D binding
protein (VDBP) showed the greatest sensitivity and specificity forM. bovis detection. CirculatingM. bovis proteins, specifically
polyketide synthetase 5, detectedM. bovis-infected cattle with little to no seroreactivity againstM. kansasii- andM. avium
subsp. paratuberculosis-infected animals. These data indicate that host and pathogen serum proteins can serve as reliable bio-
markers for trackingM. bovis infection in animal populations.
Acritical element in the prevention and control of bovine tu-berculosis (bTB) is early and unambiguous diagnosis of sub-
clinical infections. The majority of the diagnostic methods for
subclinical infections rely on immune responses, which are con-
founded by previous exposure to the suspect pathogens and cross-
reactivity with similar microbes and diseases. In order to develop
next-generation diagnostics with improved accuracy, pathogen-
specific biomarkers predictive of disease progression andoutcome
must be identified and validated.
bTB, a prevalent and devastating disease of cattle worldwide,
caused by Mycobacterium bovis, is a classic example of detection
failure and misidentification (1). The United States Department
of Agriculture (USDA) bTB eradication program relies on three
main tests: the caudal fold test (CFT), comparative cervical test
(CCT), and a gamma interferon release assay (IGRA) (Bovigam;
Prionics) (2). All three tests are labor-intensive and have logistical
challenges and sensitivity/specificity issues. For example, the CFT
lacks specificity for M. bovis infection and fails to detect all dis-
eased cattle, which is further confounded by frequent background
infection with a different pathogenic mycobacterium, M. avium
subsp. paratuberculosis (3, 4). In addition, the IGRA requires
blood samples to be processed within 24 h of collection, which
may not be feasible with large herds located in areas where a spe-
cialized laboratory is not easily accessible (2). Furthermore, vari-
ous studies suggest that the injection of tuberculin antigens used
in the CFT may impact IGRA and result in false positives; how-
ever, additional testing is needed to confirm this (5, 6). Current
testing limitations, significant economic losses, and spillover to
human and wildlife populations highlight the urgency for a mul-
tifaceted test that increases detection, limits disease exposure, and
distinguishesM. bovis infection from infections with other myco-
bacteria and diseases that impact animal and human health (7).
The elucidation and public availability of cattle and M. bovis
genomes have advanced our understanding of the host responses
to M. bovis and its genetic elements that may be regulated during
infection (8, 9). Knowledge about response elements and gene
regulation have allowed researchers to make refinements to diag-
nostics and discover approaches to aid in bTB detection (10). The
host response measures utilized for bTB diagnostics include an
array of cytokines, chemokines, and antibody responses to M.
bovis proteins (5, 11). Although these tools provide another layer
of testing, the results obtained are often confounded by cross-
reactivity due to homology between mycobacterial species (12).
Furthermore, host response testing relies on a single cutoff value
for detection, which may not be applicable to the testing needs of
all environments. For example, regions that are endemic for bTB
require diagnostic methods with a high sensitivity to eliminate all
infected cattle to control disease spread, while areas of low bTB
prevalence may seek increased specificity to minimize false posi-
tives and avoid undue economic losses.
In order tominimize cross-reactivity, we identified 32 host and
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16 pathogen circulating peptides that are unique to M. bovis in-
fection and followed up over a 5-month period using a highly
sensitive proteomics approach (13). During infection,Mycobacte-
rium-specific proteins, peptides, DNA, and lipids are released into
the circulation (14, 15) and are likely to provide unprecedented
specificity to identify M. bovis infection. We hypothesized that a
panel of biomarkers, including host andpathogenpeptides, would
establish a precise test to detect subclinical bTB infection. The
three most abundant blood serum host proteins (vitamin D bind-
ing protein [VDBP], fetuin-A, and alpha-1 antitrypsin) and three
pathogen peptides (MB1895c, MB2515c, and Pks5) identified by
isobaric tag for relative and absolute quantitation (iTRAQ) were
validated using a well-characterized cattle serum repository,
which included confirmed cases of M. bovis (n  128), bTB-ex-
posed cases (animals that were in contact with bTB-positive cat-
tle) (n  424), and negative controls (n  38). Based on our
findings, we propose that the identification of circulating patho-
gen peptides and host response proteins in serum samples may
augment diagnostics and help track disease progression across the
spectrum for other pathogenic infections.
MATERIALS AND METHODS
Sample sources. All cattle used in this study were housed according to
institutional guidelines and approved animal care protocols at the Na-
tional Animal Disease Center (NADC) (Ames, IA). Blood serum samples
used for iTRAQ analyses were obtained from calves infected withM. bovis
strain 1315 (1.0 106 CFU) at the NADC. M. bovis-infected calves were
housed in a biosafety level 3 (BSL-3) facility. The serum samples were
collected at baseline fromM. bovis-infected calves and then prospectively
for every month postinfection (p.i.) for 5 months. All calves were tested
for disease-associated immune response parameters, clinical signs, and
lesion characteristics identified at the time of necropsy. M. bovis-desig-
nated cattle were CFT positive and had lesion characteristics found at
necropsy. Field samples from bTB-infected and bTB-exposed cattle and
samples from cattle experimentally infected with M. avium subsp. para-
tuberculosis andM. kansasii were obtained from serum repositories at the
National Veterinary Services Laboratory (NVSL) (United States Depart-
ment of Agriculture, Ames, IA) and the National Animal Disease Center
(NADC) (USDA, Ames, IA), respectively (12, 16). The field samples were
collected from a single herd in California. The history of Johne’s disease in
this herd was indeterminate. The bTB infection status of each animal was
confirmed by a combination of antemortem caudal fold tests, pathogen
culture, and lesion histology at the time of necropsy. bTB-exposed ani-
malswere defined as animals that had contactwith bTB-infected cattle but
tested negative for bTB (i.e., were negative for CFT, histology, and cul-
ture). Negative controls were collected from a bTB-free dairy herd in
Minnesota (a generous gift from Paul Rapnicki). The negative controls
were defined as negative for M. bovis by culture, histology (at time of
necropsy), and CFT and did not have a history of Johne’s disease.
iTRAQ data analysis and interpretation. In our previous study, se-
rum samples from calves infected with M. bovis (n  5) and M. avium
subsp. paratuberculosis (n 5) and contemporary controls (n 5) were
pooled in equal concentrations (100 l of 100 g/l) and used in 4 indi-
vidual iTRAQ experiments: (i) M. bovis infection versus contemporary
controls, (ii) M. bovis infection versus M. avium subsp. paratuberculosis
infection, (iii) early M. avium subsp. paratuberculosis infection, and (iv)
late chronic M. avium subsp. paratuberculosis infection. A detailed de-
scription of the sample processing and analysis using iTRAQ was de-
scribed by Seth et al. (13). Host-specific peptides and relative abundance
(95% confidence interval [CI]) were identified using the ProteinPilot
software 2.0 and 2.01 (Applied Biosystems, Inc., Foster City, CA) and the
nr_bos_CTM_20070802 FASTA database. Pathogen peptides were iden-
tified using the M. bovis strain AF122 genome. At least two unique pep-
tides per protein were used as a cutoff for analysis (P 0.05 and an error
factor [EF] of 2). The EF signifies the 95%CI for an average ratio: EF
1095% CI, where the 95% CI is calculated by the formula (ratio  EF) 
(ratio/EF).
Immunoblotting for host response-associated biomarkers during
bTB infection.All procedures were developed at room temperature (RT).
Experimental field samples (128 confirmed bTB infected and 82 bTB ex-
posed) and negative controls (n 38) were spotted in duplicate and dried
on 0.2-m nitrocellulose membranes. The nitrocellulose membranes
were blocked using 1 phosphate-buffered saline (PBS)–0.05% Tween
20 (TW20) containing 5% nonfat dried milk powder with subtle shaking
for 1 h and washed 5 times in 1 PBS-TW20 in 5-min increments. The
nitrocellulose membranes were separately incubated with rabbit poly-
clonal alpha-1-antitrypsin (Abcam, Cambridge, MA), goat polyclonal fe-
tuin-A (M-17) (Santa Cruz Biotechnology, Inc., Dallas, TX), and mouse
anti-human VDBP (R&D Systems, Minneapolis, MN) diluted 1:1,000 in
PBS-TW20 containing 1% nonfat dried milk powder with shaking for 1 h
and subsequently washed as described above. The binding of primary
antibodies to serum was detected using a 1:10,000 dilution of anti-rabbit
IgG (R&D Systems), anti-mouse IgG (R&D Systems), and anti-goat IgG
(Santa Cruz Biotechnology, Inc., Dallas, TX) conjugated to horseradish
peroxidase (HRP) incubated for 1 h with shaking, followed by 5 PBS-
TW20 washes and development with Western Lightning enhanced
chemiluminescence substrate (PerkinElmer,Waltham,MA) per theman-
ufacturer’s instructions. The membranes were imaged using simple bio-
chemical acquisition fromLabWorks 4.6 software (LabWorks, Inc., Costa
Mesa, CA), and the raw density values were calculated.
Production ofmonoclonal antibodies againstM. bovis-specific pep-
tides present in the blood serum of animals infected with M. bovis.
MB2515c, MB1895c, andMB1554c (Pks5) antibodies were commercially
produced by NeoBioScience (Cambridge, MA). The proteins were se-
lected based on iTRAQ identification and potential for immunogenicity
as determined by the literature. Briefly, peptides were designed for each
protein using NeoBioScience software that considered hydrophilicity,
flexibility, accessibility, rotation, surface-exposed probability, and antige-
nicity. A Basic Local Alignment Search Tool (BLAST) search was per-
formed on M. bovis proteins to eliminate homologous sequences. Mice
(n  5 for each peptide) were initially injected intraperitoneally with a
peptide emulsion (10 to 50g) and complete Freund’s adjuvant (CFA) in
sterile saline. The immunizations were repeated 2 times using incomplete
Freund’s adjuvant (IFA) and once using PBS in place of CFA in 14- and
21-day intervals postimmunization. Every 21 days, postimmunization
blood samples were drawn from the mice and were tested against the
appropriate peptides using an indirect enzyme-linked immunosorbent
assay (ELISA). Each mouse was euthanized 61 days postimmunization
and its spleen was harvested for splenocyte extraction. Splenocytes were
fused with hybridomas, which were seeded into individual wells in a 96-
well plate and screened by ELISA to detect positive clones. The clones
19-1-1 (MB1895c), 5-1-3 (Pks5), and 3-1-2 (MB2515c) were selected,
subcloned by limiting dilution, and isotyped. The clones were expanded
and the supernatant was collected. Monoclonal antibodies were kept at
70°C until further use.
Development of an indirect ELISA to detect M. bovis-specific pep-
tides in blood serum. bTB-confirmed (n 128), bTB-exposed (n 424),
M. kansasii-infected (n 10), M. avium subsp. paratuberculosis-infected
(n 10), and negative-control (n 38) sera were individually diluted in
0.05M carbonate-bicarbonate buffer (pH, 9.6) (Sigma-Aldrich, St. Louis,
MO) at a 1:50 dilution for MB1895c and MB2515c detection and a 1:100
dilution for Pks5 detection, and 50l/well of each sample was transferred
to separate wells in Nunc MaxiSorp flat-bottom ELISA plates. Each sam-
ple was plated in triplicate. The serum samples were allowed to absorb
overnight at 4°C and the plates were washed thrice using 200 l/well of
PBS. The plates were blocked in 200 l/well of Blocker Blotto in Tris-
buffered saline (TBS) (Pierce, Rockford, IL) for 2 h at 37°C, washed thrice
using 300 l/well of 1 Femto PBS containing 0.05% TW20 (G-Biosci-
ences, St. Louis, MO), and incubated with either 100 l/well of a 1:5,000
Biomarkers of Subclinical M. bovis Infection
February 2014 Volume 52 Number 2 jcm.asm.org 537
 o
n
 Septem
ber 12, 2018 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
dilution of MB2515c or MB1895c or a 1:10,000 dilution of Pks5 resus-
pended in a 1% solution of Blocker Blotto in TBS with 0.05% TW20 for 1
h at RT. The plates were washed as described above and incubated with
100l/well of goat anti-mouse IgG-HRP (SantaCruzBiotechnology, Inc.,
Dallas, TX) diluted 1:5,000 in 1%Blocker Blotto in TBSwith 0.05%TW20
for 1 h at RT and subsequently washed. The ELISA plates were developed
with 100 l/well of 1-Step Ultra 3,3=,5,5= tetramethylbenzidine (TMB)-
ELISA (Pierce, Rockford, IL) and incubated for 30 min at RT in the dark.
The TMB reaction was stopped by adding 50 l/well of 2 M sulfuric acid,
and the optical densities at 450 nm (OD450) were recorded using the
SpectraMax M2 microplate reader and software (Molecular Devices,
Sunnyvale, CA). Positive cutoff values were calculated from the negative-
control average and two standard deviations.
Statistical analysis. To construct receiver operating characteristic
(ROC) curves for each biomarker, the test results for each animal were
averaged across the replicates and the respective coefficient of variation
was calculated (see the supplemental material). The ROC curves for host
response andM. bovis-specific biomarkers were compared using the area
under the ROC curve (AUC). Two comparisons were performed, positive
versus within-herd exposed negative controls (exposed) and positive ver-
sus not exposed negative controls (controls). The optimal cutoff values
were calculated for each biomarker by maximizing specificity (Sp) and
sensitivity (Se). The cutoff value units were based on optical density at 450
nm from ELISAs (pathogen biomarkers) and relative light units (RLU)
from dot blot analyses (host biomarkers). For the best performing bio-
marker, positive predictive values (PPV) and negative predictive values
(NPV) with respective cut point-specific likelihood ratios (LR) were cal-
culated at 4 different optimal combinations of Se and Sp in order to
develop a framework for a decision analysis algorithm inmultiple scenar-
ios of disease prevalence (17). ROC curves and sensitivity-specificity plots
were generated using SAS 9.3 (SAS Institute, Inc., Cary, NC, USA).
RESULTS
VDBP distinguishes confirmed bTB field samples from unin-
fected and exposed cattle. The top three candidates identified by
our previous study, alpha-1 antitrypsin, fetuin-A, and VDBP,
were validated for their diagnostic potential in a large-scale screen
of control andM. bovis-infected cattle (13). A total of 248 animals
(negative control [n  38], confirmed bTB [n  128], and bTB
exposed [n 82]) were tested for reactivity to alpha-1 antitrypsin,
fetuin-A, andVDBP via dot blot analysis. The area under the ROC
curve (AUC) determined that VDBP was the most reliable bio-
marker capable of differentiating negative and M. bovis-infected
animals (Fig. 1 to 3; see also Fig. S1 and S2 in the supplemental
material). The majority of the exposed cattle (81.4%) were cate-
gorized as bTB negative (Fig. 1 to 3; see also Fig. S1 and S2 in the
supplemental material). Similar to VDBP, ROC analysis of fe-
tuin-A showed a near-perfect separation (0.9949) between the
negative controls and bTB-infected animals; however, separation
between bTB-exposed and -infected animals decreased to 0.7741
FIG 1 Receiver operating characteristic (ROC) curves for host biomarkers.
Each point on an ROC curve is the fraction of bTB-positive cattle (true-posi-
tive rate) versus the corresponding fraction of negative bTB-exposed cattle
(false-positive rate). VDBP is the most reliable biomarker (AUC, 0.8860), fe-
tuin-A is a moderately reliable biomarker (AUC, 0.7741), and alpha-1 antit-
rypsin is an unreliable biomarker (AUC, 0.5425).
FIG 2 Vitamin D binding protein (VDBP) histogram. Relative densities were
collected from negative bTB-exposed (n  82) and bTB-infected (n  128)
animals. The cutoff value (38.50) was determined based on ROC analysis and
the true-negative rate versus the true-positive rate.
FIG 3 Vitamin D binding protein distinguished bovine tuberculosis-positive
and negative bTB-exposed animals. The true-negative rate and true-positive
rate using VDBP as a biomarker were plotted against each other. The optimal
cutoff value corresponded to 38.50 (raw density). The cutoff value corre-
sponds to a sensitivity (Se) of 80.597% and a specificity (Sp) of 81.7073%.
Lamont et al.
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(Fig. 1; see also Fig. S2 in the supplementalmaterial). Although the
alpha-1 antitrypsin AUC was 0.7967 for infected versus unin-
fected animals, a separation between the infected and exposed
groups was not distinguished (AUC, 0.5425) (Fig. 1; see also Fig.
S2 in the supplementalmaterial). It is important to note that herds
suspected to be infected with bTB likely will not include pristine
animals (i.e., those that are uninfected and unexposed); therefore,
we examined VDBP as a potential diagnostic marker, as the AUC
for infected versus exposed animalswas 0.8860 (Fig. 1). ROCanal-
ysis identified 5 cutoff ODs that retained high sensitivities and
specificities, which ranged from 33.25 to 40.25 nm. The true-neg-
ative rate and true-positive rate were plotted against the OD cut-
offs, and the optimal cutoff value was 38.50 nm, with a sensitivity
of 80.597% and specificity of 81.7073% (Fig. 2 and 3). Together,
these data show that VDBP is a reliable host biomarker that dis-
tinguishes negative, exposed, and bTB-infected animals.
iTRAQ identification ofM. bovis-specific proteins. Blood se-
rum samples from five calves experimentally infected withM. bo-
vis at 1 and 4months p.i. and uninfected controls were pooled and
analyzed by iTRAQ (13). Peptides were compared against those in
theM. bovis strain AF2122 genome. iTRAQ analysis identified 16
uniqueM. bovis proteins present in serum samples from calves at
4 months p.i. (Table 1).
M. bovis proteins MB1895c, MB2515c, and Pks5 are present
in bTB-positive and -suspected animals. ThreeM. bovis proteins
(MB1895c, MB2515c, and Pks5) identified in iTRAQ analysis
were selected for antibody production. Field (bTB [n 128], neg-
ative bTB-exposed [n  428], and negative-control [n  38])
animals were tested for detection with MB1895c, MB2515c, and
Pks5 antibodies. The AUC show that all three pathogen markers
easily distinguish negative from infected animals (Fig. 4). Pks5
showed the greatest separation of bTB-positive samples from bTB
exposed and negative animals (see Fig. S3 and S4 in the supple-
mental material). The cutoff values from the ROC and true-posi-
tive and true-negative rate analyses determined that the maxi-
mum sensitivity (92.188%) and specificity (93.1604%) were
achieved at 0.4 (OD450) (Fig. 4 to 6; see also Fig. S5 in the supple-
mental material). A Pks5 cutoff value of 0.3 (OD450) for the neg-
ative controls versus bTB-infected animals revealed increased sen-
sitivity and specificity at 99.219% and 100%, respectively (Fig. 5;
see also Fig. S6 in the supplemental material). However, as previ-
ously mentioned, herds suspected to be infected with bTB are
likely to contain exposed bTB cattle rather than a truly negative
population, and the application of a 0.3 cutoff may result in a
number of false-positive animals. Indeed, when applied to bTB-
exposed animals from this study, a 0.3 cutoff resulted in 10% of
TABLE 1 Proteins identified in serum samples from M. bovis calves 4
months p.i.
Locus ID Predicted function
Subcellular
location
MB2515c Transcriptional regulator (LuxR family) Cytoplasm
MB0862 Methyltransferase activity Cytoplasm
MB1482c Glucose metabolism Cytoplasm
MB2883c Aldehyde dehydrogenase activity Cytoplasm
MB1929 Redox activity Cytoplasm
MB1886c Redox activity Cytoplasm
MB1192 Hydrolase activity Cytoplasm
MB2441c Hydrolase activity Cytoplasm
MB2275 FAD binding activity Cytoplasm
MB2122c Transcriptional regulator Cytoplasm
MB1672c Conserved hypothetical protein Cytoplasm
MB1554c (pks5) Cell wall biosynthesis Cytoplasm
MB1895c Molybdenum ion binding Extracellular
MB3729c Conserved hypothetical protein Periplasm
MB1268 Transporter activity Transmembrane
MB3017c Isomerase activity Transmembrane
FIG 4 Receiver operating characteristic (ROC) curves for pathogen biomark-
ers. Each point on an ROC curve is the fraction of bTB-positive cattle (true-
positive rate) versus the corresponding fraction of negative bTB-exposed cattle
(false-positive rate). Pks5 is the most reliable biomarker (AUC, 0.9676), and
MB1895c andMB2515c aremoderately reliable biomarkers (AUC, 0.8353 and
0.7671, respectively).
FIG 5 Polyketide synthetase 5 (Pks5) histogram. Relative densities were col-
lected from negative bTB-exposed (n  428) and bTB-infected (n  128)
animals. Cutoff value (0.4 nm)was determined based on ROC analysis and the
true-negative rate versus the true-positive rate.
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animals being designated bTB positive in comparison to 6%using
a 0.4 cutoff. TheMB1895c cutoff value that provided a separation
between exposed and infected animals while retaining a high
degree of specificity was 0.2 nm (see Fig. S7 in the supplemental
material). MB2515c performed the poorest of all three patho-
gen markers, with the optimal cutoff value of 0.2 having a
sensitivity of 69.531% and specificity of 64.151% (see Fig. S8 in
the supplemental material). Together, these data show that cir-
culating pathogen peptides are detected within M. bovis-in-
fected animal serum, whichmay be utilized to distinguish control,
exposed, and infected cattle.
Application of Pks5 to detect bovine tuberculosis in a low-
prevalence region. The majority of infectious disease diagnostic
methods rely on a single cutoff value to indicate infectious status.
However, diagnostic requirements will differ between regions of
low and high prevalence for bTB. Therefore, we determined the
positive and negative predictive values of Pks5 to correctly diag-
nose bTB given disease prevalence (Fig. 2 and 3). Scenarios 1 and
2 define diagnostic test parameters applicable for bTB surveillance
in a high-prevalence area, while parameters depicted in scenarios
4 and 5 apply to low-prevalence geographic locations. In regions
of high-bTB prevalence, scenarios 1 and 2 are applicable given
increased sensitivity, while low-prevalence areas require increased
specificity (scenarios 3 and 4) (Fig. 7). The PPV for scenarios 1, 2
3, and 4 are as 1.0, 0.96, 0.9, and 0.8, respectively. TheNPV are 1.0,
0.9, 0.99, and 0.98 for scenarios 1 to 4, respectively (Fig. 7). In
order to determine the utility of Pks5 in a region that has low
prevalence for bTB and the possibility of cross-reactivity with
other pathogenic mycobacteria, we tested blood serum samples
from cattle infected with either M. avium subsp. paratuberculosis
or M. kansasii and considered the cutoff value from scenario 4
(Fig. 7). Nine out of 10 of M. avium subsp. paratuberculosis and
nine out of 10 M. kansasii serum samples tested were categorized
as being from uninfected animals under scenario 4 (low preva-
lence), and only 1 animal from each group was categorized as bTB
infected (Table 2). The data suggest that multicutoff value testing
FIG 6 Pks5 distinguished bovine tuberculosis-positive and negative bTB-ex-
posed animals. The true-negative rate and true-positive rate using Pks5 as a
biomarker were plotted against each other. The optimal cutoff value corre-
sponded to 0.4 nm. Cutoff value corresponds to a sensitivity of 92.188% and a
specificity of 93.1604%.
FIG7 Pks5 positive andnegative predictive values and cutoff values based on bovine tuberculosis prevalence. Positive andnegative predictive valueswere plotted
against percent prevalence values. Cutoff values were assigned to 4 scenarios based on prevalence. Scenario 1, high bTB prevalence (red); scenario 2, moderate
bTB prevalence (blue); scenario 3, moderate-low bTB prevalence (yellow); scenario 4, low bTB prevalence (green); Pr, probability; D(/), Disease or no
disease; T(/), test result positive or negative.
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based on prevalence will greatly aid bTB testing in various loca-
tions and that Pks5 is specifically shed, as there is minimal cross-
reactivity with other pathogenic mycobacteria infections. Further
testing using a larger number ofM. avium subsp. paratuberculosis-
and M. kansasii-infected animals will be required to validate bio-
marker specificity.
DISCUSSION
Exclusive reliance onhost-related biomarkers of infectious disease
is fraught with indeterminate results. This is largely due to cross-
reactivity with similar pathogenic and environmental bacteria and
other diseases (potentially those of a noninfectious nature).
In a previous report, using iTRAQ, we identified 32 blood se-
rum proteins specifically upregulated in M. bovis-infected cattle.
We have expanded our research to include testing of the top three
host biomarkers in an extensive and well-characterized field cattle
serum repository, including samples fromexperimentally infected
and exposed cases of M. bovis. In order to increase testing speci-
ficity, we reinterrogated the iTRAQ data sets forM. bovis proteins
with serum samples from infected animals. iTRAQ analysis iden-
tified 16 M. bovis proteins, of which 3 proteins were selected for
further testing with sera from the M. bovis cattle repository, M.
avium subsp. paratuberculosis-infected cattle, and M. kansasii-in-
fected cattle. The pathogen proteins were selected based on their
respective roles in pathogenesis and defense strategies (18–20).
The identification and validation of host- and pathogen-specific
proteins in the circulation will simplify current bTB diagnostics
and the understanding of pathogenesis in M. bovis infection.
Potential biomarker candidates. We tested three host blood
serum proteins (VDBP, alpha-1-antitrypsin, and fetuin-A) and
three pathogen proteins (MB2515c, MB1895c, and Pks5) in a
large-scale validation analysis usingwell-characterized field serum
samples fromM. bovis-infected, bTB-exposed, and negative-con-
trol animals. We showed that VDBP is the most reliable host bio-
marker that is capable of distinguishing negative, infected, and
negative bTB-exposed cases (Fig. 1; see also Fig. S2 in the supple-
mental material). Since our 2009 report, other researchers have
identified VDBP as a potential biomarker formycobacterial infec-
tion (21, 22). Tanaka et al. showed elevated VDBP levels within
active tuberculosis patients compared to in the uninfected control
group (22). VDBP has also been illustrated to be a biomarker that
can be used to diagnose M. tuberculosis infection and examine
immune responses in anthropological samples (21). We show
here that fetuin-A may be used as a biomarker to differentiateM.
bovis-infected and -uninfected animals, while alpha-1-antitrypsin
is ineffective as a diagnostic marker (see Fig. S4 and S5 in the
supplemental material). In addition to VDBP, Tanaka et al. (22)
identified fetuin-A as consistently downregulated in active tuber-
culosis cases. Differences in fetuin-A expression between the
Tanaka et al. report and our studymay be explained by the sample
source. For example, Tanaka et al. used serum samples from Jap-
anese and Vietnamese populations, which have been noted to
carry polymorphisms in the fetuin-A gene (23). Polymorphisms
within fetuin-A may contribute to decreased expression in re-
sponse to infection. In order to increase specificity, we reinterro-
gated iTRAQ data sets for M. bovis-specific proteins in infected
animal sera. Selected pathogen proteins,MB2515c,MB1895c, and
Pks5, were present in all infected animal serum samples. All three
proteins were capable of distinguishing M. bovis-infected and
-exposed cases from uninfected controls. Although all three
pathogen peptides easily separated negative from infected ani-
mals, it is important to note that animals within a herd suspected
to be infected with bTB are likely to be of an exposed status (i.e.,
have had contact with infected animals) rather than being truly
uninfected. Thus, comparisons between bTB and negative ani-
mals have a lower cutoff value, which when applied in the field,
generates a higher false-positive rate. Therefore, we examined the
ability of each pathogen marker to differentiate between infected
and exposed animals (Fig. 4). Pks5 retained a high AUC, and we
propose that this marker be used to aid current bTB testing strat-
egies.
Pks5 application in the field. Current testing strategies (CFT,
IGRA, and CCT) are based on a single cutoff value to diagnose
bTB infection, regardless of prevalence. Under the single cutoff,
CFT has a sensitivity of 84.9% and specificity of 89.2% (24).While
the comparative cervical test (CCT) has a sensitivity of 74% and a
specificity of 96%, the IGRA has a sensitivity of 83.9% and a spec-
ificity of 90.7% (25, 26). It is important to note that a “one-size-
fits-all” testing method is not appropriate for all regions, states,
and countries, and that the available diagnostic methods do not
reflect this. For example, in the United States, bTB affects0.1%
of all herds, and diagnostic methods with a cutoff based on high
sensitivity may designate animals that were exposed to other my-
cobacteria (e.g., M. avium subsp. paratuberculosis) as being bTB
positive. Misidentification will negatively impact the agricultural
economy of a low-prevalence area, and cutoff values should be
based on specificity. In contrast, in areas with a high prevalence of
bTB, it may be beneficial to have testing cutoffs with increased
sensitivity to capture all infected cattle and minimize potential
spillover to other animals and humans. Therefore, Pks5 cutoffs
were determined based on scenarios for high-prevalence (scenar-
ios 1 and 2) and low-prevalence (scenarios 3 and 4) areas (Fig. 7).
Areas that are endemic for bTB (high prevalence) are reflective of
locations, such as China, India, and Africa, which practice intense
TABLE 2 Pks5 optical densities of cattle infected with M. avium subsp.
paratuberculosis and M. kansasii
Infection type Cow no. OD450
a Scenario 4
M. avium subsp. paratuberculosis 1 0.359367 Uninfected
2 0.3472 Uninfected
3 0.1424 Uninfected
4 0.3044 Uninfected
5 0.7765 Infected
6 0.0719 Uninfected
7 0.1139 Uninfected
8 0.3467 Uninfected
9 0.0499 Uninfected
10 0.0504 Uninfected
M. kansasii 1 0.267767 Uninfected
2 0.336133 Uninfected
3 0.1369 Uninfected
4 0.3463 Uninfected
5 0.086233 Uninfected
6 0.1278 Uninfected
7 0.729833 Infected
8 0.105833 Uninfected
9 0.049667 Uninfected
10 0.083433 Uninfected
a OD450, optical density at 450 nm. The optical densities were determined in triplicate,
and the results are reported as the average for each cow/infection combination.
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farming conditions (i.e., have high animal densities in limited
space and/or shared or close living quarters with humans) and
where active control programs are scarce or inadequate. Current
diagnostic methods lack sufficient sensitivity to capture the ma-
jority of bTB-infected animals; therefore, there is substantial con-
cern that bTB will spread to other animals within the herd, neigh-
boring herds, and potentially to humans. bTB transmission to
humans is also enhanced under these conditions given that high-
prevalence areas typically associated with developing countries do
not enforce the pasteurization of milk and milk products (27).
Thus, bTB animals that are not identified under available diagnos-
ticmethodswill continue to be employed formilk production and
impact human health. Examples of areas with low bTB prevalence
are the United States and Canada, in which active control and
surveillance programs are in place and farming practices are ad-
justed to meet control program recommendations and guidelines
aswell as availability for education/training for farmers.Under the
current bTB testing strategy, M. avium subsp. paratuberculosis-
infected or vaccinated cattle are likely to test CFT positive and
result in an unnecessary economic loss for the farmer. Further-
more, not all bTB-exposed cattle will become infected or progress
to subclinical infection and later clinical disease. This would result
in the undue culling of valuable animals. Therefore, the economic
well-being of the farmer should be valued, and increased specific-
ity should be utilized. Although our results indicated that Pks5
may serve as a diagnostic tool forM. bovis infections, the possibil-
ity remains that these proteins might react with other pathogenic
mycobacteria. Therefore, we tested serum samples from animals
infected with M. avium subsp. paratuberculosis and M. kansasii
(Table 2).We show limited cross-reactivity of Pks5 withM. avium
subsp. paratuberculosis- and M. kansasii-infected sera (Table 2).
The results from this study as well as the scientific literature indi-
cate that VDBP, fetuin-A, MB1895c, MB2515c, and Pks5 can be
used as a panel of biomarkers to aid in current M. bovis diagnos-
tics.
Although host and pathogen blood serum proteins serve as
diagnostic biomarkers of M. bovis infection, tests in the form of
dot blots and ELISAs are not feasible in the field. The goals of any
diagnostic method are to have sensitive, specific, and rapid results
as well as ease of testing. We propose that the application of an
appropriate point-of-care/testing device such as a nanosensormi-
crofluidic apparatus or portable surfaced-enhanced Raman spec-
troscope using these biomarkers may be more convenient and
provide better throughput (28, 29).
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